Clinical Trial,urls,Unnamed: 2,Biological Sex,BMI (kg/m^2),Age,Smoking status,Current Medication,Health Conditions,Regular menstruation?,PCOS,Age_Min,Age_Max,BMI_Min,BMI_Max
Dampening the Reproductive Axis With Continuous Kisspeptin,https://clinicaltrials.gov/study/NCT05971849,RECRUITING,0,0-100,18-45,0,1,Reproductive Disorder|PCOS|Polycystic Ovary Syndrome,1,1,18,45,0.0,100.0
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens,https://clinicaltrials.gov/study/NCT05370521,COMPLETED,0,0-100,18-40,0,1,Polycystic Ovary Syndrome,1,1,18,40,0.0,100.0
Kisspeptin Administration in the Adult,https://clinicaltrials.gov/study/NCT00914823,COMPLETED,0,0-100,21-40,0,0,Hypogonadotropic Hypogonadism|Kallmann Syndrome|GnRH Deficiency|PCOS|Polycystic Ovarian Syndrome|Hyperprolactinemia but NO ,0,1,21,40,0.0,100.0
A Cooking and Eating Study,https://clinicaltrials.gov/study/NCT01079845,TERMINATED,0,25-29.9,13-21,1,1,Polycystic Ovary Syndrome,0,1,13,21,25.0,29.9
Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome,https://clinicaltrials.gov/study/NCT03951077,COMPLETED,0,18.5-38,18-35,0,0,Polycystic Ovary Syndrome,1,1,18,35,18.5,38.0
Polycystic Ovary Syndrome Genetics and Treatment Response,https://clinicaltrials.gov/study/NCT01389778,UNKNOWN,0,0-100,18-40,0,0,Polycystic Ovary Syndrome,0,1,18,40,0.0,100.0
Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT,https://clinicaltrials.gov/study/NCT01672801,COMPLETED,0,0-100,25-40,0,0,Unexplained Infertility|Polycystic Ovarian Syndrome|Anovulatory,1,1,25,40,0.0,100.0
Apple Women's Health Study,https://clinicaltrials.gov/study/NCT04196595,RECRUITING,0,0-100,18-99,0,1,Menstrual Cycle|Ovulation|Menstruation|Polycystic Ovary Syndrome|Infertility|Menopause|Reproduction|Reproductive Health,1,1,18,99,0.0,100.0
